Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

536
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
536
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseases.

BMJ open respiratory research·2026
Same author

Correction: Progressive pulmonary fibrosis.

European radiology·2026
Same author

Case Report: Decoding genetic risks of vascular parkinsonism: a case series.

Frontiers in genetics·2025
Same author

APOE genetic variability in an Egyptian cohort of PD.

Frontiers in neuroscience·2025
Same author

Evaluation of the safety of short-term follow-up CT for the management of consolidation in lung cancer screening.

European radiology·2025
Same author

Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival.

Rheumatology (Oxford, England)·2024

相关实验视频

Updated: Jan 8, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

860

渐进的肺纤维化

Ramey Bajwa1, Drew Lancaster2, Sujal R Desai3,4

  • 1Department of Interstitial Lung Disease, Royal Brompton Hospital, London, UK. rameybajwa@gmail.com.

European radiology
|December 19, 2025
PubMed
概括

渐进性肺纤维化 (PPF) 模仿异常性肺纤维化 (IPF) 并增加死亡率. 在CT扫描上识别放射性进展对于及时的抗纤维素治疗和减缓肺功能下降至关重要.

关键词:
抗纤维素药物 抗纤维素药物计算机断层扫描 (CT) 是一种计算机断层扫描.尼丁达尼比是什么意思渐进的肺纤维化纤维化的放射性进展.

更多相关视频

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

807
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.5K

相关实验视频

Last Updated: Jan 8, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

860
Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
07:11

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

807
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.5K

科学领域:

  • 肺部病理学 肺部病理学
  • 放射学 放射学是一门学科.
  • 医疗成像医学成像

背景情况:

  • 一部分非异形性肺纤维化 (IPF) 病例表现出渐进性肺纤维化 (PPF) 的发展轨迹.
  • PPF与患者死亡率的增加有关,并且在临床上模仿IPF.
  • 识别PPF对于患者的管理和预后至关重要.

研究的目的:

  • 定义用于识别PPF的放射性进展标准.
  • 突出放射科医生在管理PPF患者中的作用.
  • 强调早期检测对于抗纤维素治疗的重要性.

主要方法:

  • 序列高分辨率计算机断层扫描 (CT) 扫描的分析.
  • 评估纤维化程度和严重程度的变化随着时间的推移.
  • 对非IPF病例的进展进行放射学评估.

主要成果:

  • 在PPF的放射性进展的特点是整体纤维化程度的增加.
  • 进展也可以表现为纤维化严重程度的增加,总体程度没有变化.
  • 精确的放射性识别可以及时进行干预.

结论:

  • 放射科医生是通过CT评估诊断PPF的关键.
  • 识别放射性进展允许启动抗纤维菌药物.
  • 早期的抗纤维素治疗可以显著缓解PPF的肺功能下降.